Press Releases

Date	Title and Summary	Additional Formats
December 11, 2003	Aastrom's Dendritic Cell Vaccine Technology to be Utilized in Duke University's Clinical Trial for New Cancer Treatment	View HTML Aastrom's Dendritic Cell Vaccine Technology to be Utilized in Duke University's Clinical Trial for New Cancer Treatment
November 14, 2003	Aastrom Biosciences Holds Investor Conference Call Today	View HTML Aastrom Biosciences Holds Investor Conference Call Today
November 12, 2003	Aastrom Biosciences to Hold Investor Conference Call	View HTML Aastrom Biosciences to Hold Investor Conference Call
November 10, 2003	Aastrom Biosciences, Inc. Reports First Quarter 2004 Financial Results	View HTML Aastrom Biosciences, Inc. Reports First Quarter 2004 Financial Results
November 4, 2003	Aastrom Biosciences Launches Direct Stock Purchase Program	View HTML Aastrom Biosciences Launches Direct Stock Purchase Program
October 17, 2003	Aastrom Biosciences to Present at Fifth Annual Rodman & Renshaw Techvest Healthcare Conference	View HTML Aastrom Biosciences to Present at Fifth Annual Rodman & Renshaw Techvest Healthcare Conference
October 14, 2003	Herbert S. Schwartz, M.D. Appointed to Aastrom Biosciences' Technology Review Board	View HTML Herbert S. Schwartz, M.D. Appointed to Aastrom Biosciences' Technology Review Board
October 6, 2003	Aastrom Biosciences Receives NIH Grant to Develop Stem Cell Treatment for Diabetic Circulation Disorders	View HTML Aastrom Biosciences Receives NIH Grant to Develop Stem Cell Treatment for Diabetic Circulation Disorders
September 15, 2003	Aastrom Biosciences Receives NIH Grant for Dendritic Cell Vaccine Research	View HTML Aastrom Biosciences Receives NIH Grant for Dendritic Cell Vaccine Research
September 2, 2003	Aastrom Biosciences Receives FDA Approval to Initiate Multi-Center Clinical Trial for Bone Graft Product	View HTML Aastrom Biosciences Receives FDA Approval to Initiate Multi-Center Clinical Trial for Bone Graft Product

Investor Relations

Press Releases

Company Presentation